Company News
Stifel Picks DexCom as Top MedTech Bet
Stifel designates DexCom as its top pick in medical tech, citing strong Q2 2026 results and raised outlook.
DexCom reported Q2 2026 revenue of $1.308 billion, a 12% YoY organic increase, beating conse
